After the Invima confirm that it endorsed the protocols, the pharmacist Sanofi Pasteur announced that phase III of the clinical trials of the vaccine against Covid-19 which is developing together with the British laboratory GSK, a process that will be carried out in 7 research in the cities of Bogotá, Barranquilla, Cali, Florida Blanca, Santander; Soledad, Atlantic; Chia and Girardot, Cundinamarca.
“We need approximately 2,500 volunteers, over 18 years of age in the different cities where we are going to carry out the study. This is a test in phase III, in which the medicine, in this case the vaccine, in a significant number of people, after having undergone the phases I and II, where the safety of the drug and also the efficacy, “he said. Humberto Reynales placeholder image, Investigator of the Clinical study in Colombia.
Those interested in participating in the study should contact directly with research centers such as the Hospital University of the North Foundation, in Soledad, Atlántico; Cínica de la Costa Ltda in Barranquilla; the Study Center in Infectology Pediatric in Cali; the Cardiovascular Foundation of Colombia in Floridablanca and the Attention and Research centers Medical in Bogotá, Chía and Girardot.
According to these laboratories, estimate that, depending on the positive results of Phase III and the reviews regulatory, the vaccine could be licensed in the bedroom Quarter 2021. Manufacturing will begin in the next few weeks to allow quick access should it be authorized.